Delivery Order SPE2DB22D1017-SPE2DB25FYRFV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with a completion date of September 26, 2025. This is a firm fixed-price contract awarded competitively without a set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger vehicle, this delivery order leverages AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a $9,925.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with performance in Conshohocken, Pennsylvania and completion targeted for September 26, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. ProQuad is a combination vaccine used for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,055.26 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of ProQuad vials. The contract features firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by September 23, 2025, at the vendor's Conshohocken facility. This delivery order operates as...
- The Defense Logistics Agency awarded a delivery order valued at $5,480.80 to AmerisourceBergen Drug Corp for PROQUAD vials, a vaccine product, with a completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order was placed with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,543.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 12, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,687.48 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for ProQuad vials with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationships with DLA for pharmaceutical supply to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,271.65 by the Defense Logistics Agency on July 22, 2025, for the supply of ProQuad vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,118.64 to AmerisourceBergen Drug Corp for the supply of ProQuad vials. The contract, issued on August 12, 2025, with a completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee and will perform the work at its corporate office location. This delivery order is a child contract...
- AmerisourceBergen Drug Corp was awarded a $6,683.60 delivery order by the Defense Logistics Agency (DLA) for PROQUAD vials, with performance in Conshohocken, Pennsylvania. The contract is not set-aside, was competitively awarded at firm fixed price, and carries an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRFVDelivery Order
The Defense Logistics Agency (DLA) awarded a $5,372.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of October 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. PROQUAD is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, reflecting the contract's focus on pharmaceutical and medical supply distribution to support military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills a critical role in the federal medical procurement supply chain. The company's extensive portfolio of federal contracts with DLA demonstrates its capability to provide comprehensive pharmaceutical products and medical commodities across multiple therapeutic domains, including vaccines, specialty medications, and medical supplies to support Defense Health Agency and other federal healthcare beneficiaries globally. This delivery order exemplifies the company's ongoing role as a preferred vendor for routine medical supply procurement within the DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/18/25 |